Baxter International has announced an IV fluid recall involving several injectable medications after concerns about the possible presence of foreign particles in the products. The recalls announced in August 2026 involve injectable products supplied in VIAFLEX plastic containers, with the U.S. Food and Drug Administration listing the affected products and recall reasons in its drug-recall database.
The recalled products include 0.9% Sodium Chloride Injection, Anticoagulant Sodium Citrate Solution and 70% Dextrose Injection. According to FDA information, the sodium chloride and sodium citrate products may contain fiberglass particulate matter, while the dextrose injection may contain stainless-steel particles.
Foreign Particles Raise Concerns
The presence of particulate matter in injectable medicines is a significant quality concern because these products are administered directly into the body. The FDA describes drug recalls as actions taken to remove defective or potentially harmful medicines from the market and provides a searchable database of current recalls for consumers and health professionals.
Baxter’s recalls were announced on August 25 and August 26, adding several products to the FDA’s list of recently recalled injectable medicines. The agency’s records identify the specific contamination concerns associated with each product, allowing healthcare providers and distributors to determine which products may be affected.
What Patients and Providers Should Know
Healthcare professionals and medical facilities that use injectable medications should check their supplies against the official recall information before administering affected products. Because injectable medicines are commonly used in hospitals and other healthcare settings, identifying recalled lots and removing them from use is an important part of the recall process.
Patients who believe they may have received an affected medication should not stop or change prescribed treatment without speaking with a healthcare professional. Injectable medicines can be used for many different medical purposes, so the appropriate response depends on the specific product and the patient’s treatment.
The latest Baxter recalls highlight the importance of manufacturing controls and quality checks for injectable medicines. Foreign particles such as fiberglass or metal can result in products being removed from distribution while regulators and manufacturers address potential quality problems.
The FDA continues to maintain its drug-recall database, where consumers and healthcare professionals can review recent recalls and the reasons behind them. The agency’s August listings show that Baxter is among several manufacturers involved in recent injectable-product recalls related to particulate contamination.
For anyone handling injectable medications, checking the product name, packaging and recall information is essential. The recalls do not mean that every Baxter injectable product is affected; the FDA listings identify specific products involved in the actions. Healthcare providers should rely on the official recall notices and manufacturer instructions when determining whether a product should be removed from use.
Source : usatoday.com
The 2DayBulletins Editorial Team publishes accurate, timely, and well-researched news and articles across Trending Topics , Business and Finance , Politics, Entertainment, Sports, Technology, Health, with a focus on delivering reliable information to readers.